source
- Podcast examines Merck and Moderna’s mRNA cancer vaccine data presented at ESMOThe latest episode of STAT’s biotech podcast "The Readout LOUD" focused on the mRNA cancer vaccine being co‑developed by Merck and Moderna, using data shown at the European Society for Medical Onco…
- Astellas commits up to $285M upfront for Audax's preclinical IL-12 program, with potential $1.05B milestonesAstellas Pharma has entered a licensing agreement with Audax Biosciences to gain rights to the latter’s IL-12 immuno‑oncology candidate DAX‑044. Under the deal, Astellas will pay up to $285 millio…